1. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance
- Author
-
Ansari, S, Hays, JP, Kemp, A, Okechukwu, R, Murugaiyan, J, Ekwanzala, MD, Ruiz Alvarez, MJ, Paul-Satyaseela, M, Iwu, CD, Balleste-Delpierre, C, Septimus, E, Mugisha, L, Fadare, J, Chaudhuri, S, Chibabhai, V, Wadanamby, JMRWW, Daoud, Z, Xiao, Y, Parkunan, T, Khalaf, Y, M'Ikanatha, NM, Van Dongen, MBM, Global AMR Insights Ambassador Network, Barkema, HW, Strathdee, S, Benyeogor, E, Ighodalo, UL, Prasad, KP, Carlos, M, Gu, Y, Essack, S, De Silva, D, Vellinga, A, Mommtaz Ghannam, W, Tsoho, NA, Sakeena, MHF, Ilenwabor, R, Shetty, D, Ayebare, A, Traore, ZI, Henry, O, Kiran, A, Ilanwabor, R, Toro, LF, Smail, A, Amulele, A, Founou, LL, Sawant, PS, Buregyeya, E, Castro-Sánchez, E, Moreno-Morales, J, Izadjoo, M, Gori, A, Goff, D, Blocker, A, Forte, G, Tahir, MF, Diggle, M, Chakraborty, D, Asamoah, AE, Aberi, H, and Medical Microbiology & Infectious Diseases
- Subjects
0301 basic medicine ,microbial ,medicine.medical_specialty ,pathogenic organism ,diagnosis ,coronavirus ,Review ,biocides ,antibiotics ,antimicrobials ,03 medical and health sciences ,0302 clinical medicine ,Antibiotic resistance ,SDG 3 - Good Health and Well-being ,Pandemic ,medicine ,Global health ,Antimicrobial stewardship ,Infection control ,critical illness ,AcademicSubjects/MED00740 ,030212 general & internal medicine ,infections ,antimicrobial stewardships ,Intensive care medicine ,coronavirus pandemic ,ars-cov-2 ,drug resistance ,business.industry ,Public health ,world health ,Antimicrobial ,vaccination ,Vaccination ,030104 developmental biology ,AcademicSubjects/MED00290 ,covid-19 ,business ,AcademicSubjects/MED00230 - Abstract
The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic’s potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic’s effect on global AMR.
- Published
- 2021